# A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke

> **NCT02928393** · PHASE2 · TERMINATED · sponsor: **Hoffmann-La Roche** · enrollment: 5 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Basmisanil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02928393
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-20
- **Primary completion:** 2017-11-03
- **Final completion:** 2017-11-03
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Low participant enrolment
- **Last updated:** 2019-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02928393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02928393, "A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02928393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*